Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets.

Endocrinology | 2015

Pathways that stimulate β-cell regeneration remain of great clinical interest, yet effective therapeutic avenues that promote survival or reconstitution of β-cell mass remain elusive. Using a mouse model with inducible β-cell apoptosis followed by adiponectin-mediated regeneration, we aimed to identify key molecules boosting β-cell viability. In the regenerating pancreatic islets, we examined changes within the transcriptome and observed an extensive up-regulation of genes encoding proteins involved in lipid transport and metabolism. The most prominent targets were further confirmed by quantitative PCR and immunofluorescence. Among the upstream regulators predicted by pathway analysis of the transcriptome, we detected enhanced levels of 2 key transcription factors, Hepatocyte Nuclear Factor 4α and Peroxisome Proliferator-Activated Receptorα. Our data suggest that improving pancreatic islet lipid metabolism as an important antilipotoxic phenomenon to boost β-cell regeneration. This is primarily mediated by the adipokine adiponectin that exerts its action on both the beta-cell directly as well as on the adipocyte. Adiponectin induces lipid metabolism gene expression in regenerating islets through Hepatocyte Nuclear Factor 4α and Peroxisome Proliferator-Activated Receptorα. Adiponectin also modulates leptin levels via preserving adipose tissue mass in the insulinopenic state.

Pubmed ID: 25815422 RIS Download

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: K99 DK094973
  • Agency: NIDDK NIH HHS, United States
    Id: P01 DK088761
  • Agency: NIDDK NIH HHS, United States
    Id: R00 DK094973
  • Agency: NIDDK NIH HHS, United States
    Id: R01-DK55758
  • Agency: NIDDK NIH HHS, United States
    Id: P01-DK088761
  • Agency: NIDDK NIH HHS, United States
    Id: R01-DK099110
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK099110
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK055758

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Insulin (antibody)

RRID:AB_10013624

This polyclonal targets Porcine pancreatic insulin

View all literature mentions

FABP1 Antibody (antibody)

RRID:AB_11217427

This polyclonal targets FABP1

View all literature mentions

MUP (FL-180) (antibody)

RRID:AB_1126410

This polyclonal targets Mouse MUP

View all literature mentions

Apolipoprotein B antibody (antibody)

RRID:AB_2056954

This polyclonal targets Apolipoprotein B

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

apoE (M-20) (antibody)

RRID:AB_634036

This polyclonal targets apoE

View all literature mentions

Nkx-6.1 (N-15) (antibody)

RRID:AB_650286

This polyclonal targets NKX6-1

View all literature mentions